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AbstrACt
Introduction Managing nutrition is critical for reducing 
morbidity and mortality in patients on haemodialysis but 
adherence to the complex dietary restrictions remains 
problematic. Innovative interventions to enhance the 
delivery of nutritional care are needed. The aim of this 
phase II trial is to evaluate the feasibility and effectiveness 
of a targeted mobile phone text messaging system to 
improve dietary and lifestyle behaviours in patients on 
long-term haemodialysis.
Methods and analysis Single-blinded randomised 
controlled trial with 6 months of follow-up in 130 
patients on haemodialysis who will be randomised to 
either standard care or KIDNEYTEXT. The KIDNEYTEXT 
intervention group will receive three text messages 
per week for 6 months. The text messages provide 
customised dietary information and advice based on 
renal dietary guidelines and general healthy eating 
dietary guidelines, and motivation and support to improve 
behaviours. The primary outcome is feasibility including 
recruitment rate, drop-out rate, adherence to renal 
dietary recommendations, participant satisfaction and a 
process evaluation using semistructured interviews with 
a subset of purposively sampled participants. Secondary 
and exploratory outcomes include a range of clinical and 
behavioural outcomes and a healthcare utilisation cost 
analysis will be undertaken.
Ethics and dissemination The study has been approved 
by the Western Sydney Local Health District Human 
Research Ethics Committee—Westmead. Results will be 
presented at scientific meetings and published in peer-
reviewed publications.
trial registration number ACTRN12617001084370; Pre-
results.
IntroduCtIon
Chronic kidney disease (CKD) is recognised 
as a global public health problem that 
affects ~13% of the population globally, and 
continues to increase.1 2 Compared with the 
general population, people with CKD have 
an increased risk of mortality from 1.2 times 
higher in those with mild dysfunction in 
early CKD to 5.9 times higher in patients on 
dialysis.2 
In CKD, dietary management plays an 
important role in preventing the development 
and progression of CKD, improving clinical 
outcomes (eg, proteinuria, hypertension), 
reducing symptom burden and managing 
electrolyte abnormalities frequently seen 
in end-stage kidney disease, particularly in 
people requiring haemodialysis.3 Dietary 
management in patients on haemodialysis 
is particularly challenging because patients 
have to integrate complex and restrictive 
strengths and limitations of this study
 ► Mobile phone technology is inexpensive and widely 
available, and has been found to be effective in im-
proving clinical outcomes in some chronic diseases, 
including cardiovascular disease.
 ► This intervention will be evaluated in a randomised 
controlled study, with outcome assessors and stat-
istician blinded to participant allocation.
 ► The trial will be conducted in Australia and recruit 
participants from culturally diverse populations.
 ► Dietary intake will be measured using patients’ 
self-report. Self-reported dietary intake may not 
accurately reflect an individual’s actual intake; how-
ever, we are using validated 24-hour dietary recall 
methodology to standardise dietary intake assess-
ment and minimise bias.
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dietary requirements specific to CKD such as restricting 
protein, fluid, sodium, potassium and phosphorus. In 
addition, they may need to follow recommendations for 
comorbidities such as diabetes, as well as following general 
healthy eating principles.4 Furthermore, dietary prescrip-
tion can vary substantially among patients depending on 
age, comorbidities and goals of treatment.5 In the haemo-
dialysis population, educating patients about end-stage 
kidney disease fosters capacity for self-management and 
shared decision-making, which can in turn contribute 
to improved health-related behaviours (eg, diet, exer-
cise and smoking cessation)6 and reduce burden on the 
healthcare system.
Patients and health professionals have identified life-
style and nutrition as a high-priority research topic7 8 
and is an important clinical management intervention 
that reduces symptom burden and acute medical events 
due to electrolyte abnormalities, as well as enhancing 
patients’ quality of life.9 However, dietary prescription on 
haemodialysis is often seen as restrictive and difficult for 
patients to adhere to.4 Patients have reported that one off 
didactic education sessions are overwhelming and diffi-
cult to comprehend, particularly at the time of diagnosis.4 
Dietary-related behaviour change and self-management 
may be most effectively achieved through individualised 
education with a dietitian, frequent feedback and moni-
toring and longer duration of intervention (eg, at least 
6 months).10 11 Patient-centred interventions that are 
individualised and provide progressively simple to more 
complex education over time to support and engage 
patients may help to improve outcomes in this population.
Electronic health interventions (eHealth) refers to 
‘health services and information delivered or enhanced 
through the internet and related technologies’.12 eHealth 
interventions improve consumer access to relevant health 
information, enhances the quality of care and encour-
ages the adoption of healthy behaviours.12 Globally, the 
use of technology is increasing; with a median of 87% of 
people regularly using the internet in high-income coun-
tries and a median of 54% of people regularly use the 
internet in developing countries.13 Australia has one of 
the highest rates of mobile phone ownership, with 88% 
of Australians owning a smart phone.14 Given this, there 
is increasing interest in the use of eHealth in healthcare. 
Systematic reviews have shown that eHealth interventions 
are effective in changing health-related behaviour and in 
improving outcomes in patients with diabetes and cardio-
vascular disease.15–19 Specifically, telehealth (ie, the use of 
telecommunication techniques to provide health educa-
tion remotely)20 and mobile phone text messaging21 have 
shown positive improvements in dietary behaviours and 
clinical outcomes when compared with usual care in 
people with chronic diseases (eg, chronic lung disease, 
diabetes) and coronary heart disease, respectively.
There is a paucity of research using eHealth inter-
ventions, particularly interventions utilising mobile 
phone technologies, to target diet and lifestyle in the 
haemodialysis population.22 There is some indication 
that using electronic self-monitoring apps with addi-
tional dietary counselling may improve dietary sodium 
intake23 24 in haemodialysis and peritoneal dialysis popu-
lations; however, these studies were small and of short 
duration. In coronary heart disease, mobile phone text 
messaging has been shown to improve both dietary and 
clinical outcomes in patients, and to be well accepted, with 
>90% of participants reporting that the text messaging 
was useful and easy to understand.21 Given the complexity 
of dietary requirements in haemodialysis and the diffi-
culty patients have in comprehending and integrating 
these requirements, text messaging offers an inexpensive 
and readily available way to motivate and help patients 
with managing their diet by providing frequent, short 
bursts of information over an extended period of time.
The aim of this study is to assess the feasibility and 
effectiveness of a mobile phone text message interven-
tion to improve dietary and lifestyle behaviour in patients 
on haemodialysis. The results of this study will inform a 
larger trial.
MEthods And AnAlysIs
design
The design and development of KIDNEYTEXT has been 
underpinned by frameworks for the development of 
complex interventions25 and a range of behaviour change 
frameworks.26 KIDNEYTEXT is a 6-month single-blinded 
randomised controlled trial, with a 2:1 allocation ratio 
(figure 1).
study setting
This study will be conducted in six dialysis units across 
three local health districts in Sydney, Australia that serves 
ethnically, culturally and socioeconomically diverse 
populations.
study population
A total of 130 patients receiving maintenance haemodi-
alysis will be included. Patients receiving maintenance 
haemodialysis in the three local health districts in Sydney, 
Australia will be eligible to enrol in the study. Eligibility 
criteria include receiving maintenance haemodialysis 
for at least 90 days, aged 18 years and over, having suffi-
cient English language skills to read and understand 
text messages and having access to a mobile phone 
throughout the duration of the study. If patients do not 
have their own mobile phone, a partner or close family 
member involved in meal provision may consent to have 
their mobile phone number used throughout the trial. 
Patients will be ineligible if they are prescribed a diet, that 
is, incongruent with standard renal dietary education (eg, 
immediately post bariatric surgery), acutely unwell (eg, 
septic), if they are not expected to be on haemodialysis 
for the forthcoming 6 months (eg, change of dialysis 
modality or transplantation), if they have a life expec-
tancy of <12 months, pregnant or breastfeeding or if 
they have significant cognitive impairment or intellectual 
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disability that would inhibit their understanding of the 
text messages. A ‘screening log’ containing basic demo-
graphic information and reason for non-participation 
will be kept for patients who are ineligible or decline to 
participate.
Interventions
Participants will be randomly allocated to either control 
or intervention group. The control group will continue 
to receive standard care provided by the dialysis unit 
that they attend. Standard care practices may differ 
between dialysis units; however, there will be no change 
to frequency of usual dietetic consultations or service 
delivery throughout the study.
The KIDNEYTEXT intervention group will receive 
standard care plus they will receive three text messages 
per week over a 6-month period. Text messages will be 
unidirectionall (ie, one-way with no response required 
from participants), as they are intended to function as 
reminders and reinforcements of various dietary compo-
nents. Unidirectional text messages have improved dietary 
and lifestyle behaviours in patients with coronary heart 
disease21 and are more time and cost-effective compared 
with in-person interventions. The messages will provide 
advice, information, motivation and support to improve 
renal dietary behaviours (related to potassium, phos-
phorus, sodium, fluid) and general healthy eating and 
lifestyle behaviours (box 1). From baseline to 3 months, 
patients may receive messages relating to dietary modifi-
cation of potassium, phosphorus and sodium and fluid 
(figure 2). Participants will receive messages relating to 
potassium if one or both of the following guidelines is 
exceeded.
1. Baseline dietary intake exceeds guidelines for potassi-
um (1 mmol/kg of ideal body weight per day).27
2. Two of three previous predialysis serum potassium lev-
els exceeds 5.5 mmol/L.28 Baseline blood values will 
be based on the previous three routine dialysis blood 
tests.
Figure 1 Study design and flow.
box 1 Examples of text messages to be sent to the 
KIdnEytEXt intervention group
Potassium
 ► Did you know the way you cook your vegetables can change their 
potassium content? Boil vegetables in water to get rid of some 
potassium.
 ► Not sure what is causing high potassium levels? Write down every-
thing you are eating and drinking and discuss with your dietitian.
 ► How much dairy do you have? Limit to 250 mL milk and milk prod-
ucts (eg, yoghurt and custard) daily to help control your potassium 
levels.
Phosphorus
 ► Phosphate is added to prepackaged foods and convenience foods. 
Choose fresh foods to reduce how much phosphate you eat.
 ► Phosphate binders act like a magnet and stop you from absorbing 
some phosphate. Take your phosphate binders with your meals so 
that they work properly.
sodium and fluid
 ► Make sure you know what is in your foods! Look for foods that con-
tain <400 mg/100 g of sodium.
 ► To get more flavour into your food use pepper, chilli, herbs and spic-
es in your cooking.
 ► Use smaller cups to help reduce how much you drink.
General healthy eating and lifestyle
 ► Getting enough physical activity? Set regular goals to help you get 
to your target. Start small and build up over time. Every bit helps.
 ► Include low potassium fruits and vegetables daily to make sure you 
get enough fibre.
 ► Are you a bit off your food? Including small snacks can be a good 
way to keep up your nutrition.
 ► The colour of vegetables gives a clue to what nutrients they contain. 
By including a variety of colours you will get more vitamins and 
nutrients.
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Participants will receive messages relating to phos-
phorus if one or both of the following guidelines is 
exceeded:
1. Baseline dietary intake exceeds guidelines for phos-
phorus (>1000 mg/day).27
2. Two of three previous predialysis serum phosphate lev-
els exceeds 1.78 mmol/L.29 Baseline blood values will 
be based on the previous three routine dialysis blood 
tests.
Participants will receive messages relating to sodium 
and fluid if one or both of the following guidelines is 
exceeded:
1. Baseline dietary intake exceeds guidelines for sodium 
(>2300 mg/day).27
2. An average of interdialytic fluid gains from the previ-
ous three dialysis sessions being >3.5% of body weight 
or ≥3 kg.30
If a participant satisfies all of these guideline criteria 
they will only receive general healthy eating and lifestyle 
messages from baseline to 3 months.
From 4 to 6 months, all participants will receive 
general healthy eating and lifestyle messages that are 
congruent with renal dietary guidelines (figure 2). 
Feedback regarding participants’ biochemical and clin-
ical parameters will continue to be provided as per the 
standard care of each dialysis unit (eg, via nursing and 
medical staff).
Message delivery will be managed by computerised 
software (TextQStream, Python V.3.6 using Pycap V.1.02 
library) that was developed and customised in-house for 
use in this trial. Computer software is run through the 
University of Sydney RedCap system. The programme will 
keep a log of all messages sent to each participant. The 
messaging engine will send messages through a gateway 
interface that can be sent through Australian phone 
network at no cost to the participant. Data exports will 
be compliant with privacy legislation and held in strict 
privacy, centrally managed at Westmead Hospital. There 
will be no access to data by any third party, including the 
software developers.
Figure 2 Text message allocation.
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While participants are asked not to respond to text 
messages, a record of any text messages received from 
participants will be kept and managed by a researcher 
who is not involved in recruitment or outcome assess-
ment. Participants will have the opportunity to withdraw 
via a text message and the researcher will contact the soft-
ware manager in order to initiate the withdrawal.
KIDNEYTEXT intervention development
In total, 160 text messages have been systematically devel-
oped through an iterative process and based on renal 
dietary recommendations27–30 and general healthy eating 
guidelines.31 Messages targeting renal-specific dietary 
components provide advice to assist participants in 
reducing their intake of potassium, phosphorus, sodium 
and fluid and provide prompts for self-monitoring and 
self-management behaviours. General healthy eating and 
lifestyle messages promote general healthy eating princi-
ples, such as increasing dietary fibre, encouraging phys-
ical activity and improving medication management.
The text message bank was developed in three stages. 
Initially, text messages were developed using behaviour 
change frameworks including information–motivational–
behavioural skills model, theory of reasoned action, 
theory of planned behaviour and social cognitive theory.26 
Table 1 outlines behaviour change techniques with exam-
ples of text messages used in KIDNEYTEXT.
Text message content was assessed for readability using 
Flesh-Kincaid, with an average Flesh-Kincaid score of 6 
or less being deemed appropriate. An expert review 
panel including renal dietitians, nephrologists, renal 
nurses and social scientists then reviewed each message 
to ensure the content of the messages were accurate. The 
final draft of text messages were reviewed by people on 
haemodialysis, caregivers and public health researchers 
who rated the usefulness and understanding of the text 
messages on a five-point Likert scale with additional space 
for comments. Feedback from these ratings was incorpo-
rated into the final draft of text messages for the KIDNEY-
TEXT intervention.
Patient and public involvement
We sought feedback from people on haemodialysis during 
the design and development stages of KIDNEYTEXT. We 
conducted semistructured interviews with 35 patients on 
haemodialysis to elicit their perspectives regarding the 
use of eHealth, particularly mobile phone technology to 
support current nutritional management. Based on these 
interviews, three text messages per week were indicated 
as an acceptable frequency of receiving text messages. 
We incorporated feedback from these interviews into 
the design of KIDNEYTEXT. Once an initial bank of text 
messages was developed, we asked patients to review all 
message content for accuracy, relevancy and usability. 
Each message was reviewed by at least three consumers 
and we integrated their feedback into the final set of 
text messages for use in the trial. A process evaluation 
exploring the feasibility of the trial, including burdens 
and benefits to participants, will be undertaken at the 
completion of the trial. We will disseminate deidentified 
findings from the trial to study participants and dialysis 
units at the completion of the trial.
study outcomes
The primary outcome will be the feasibility of the mobile 
phone text messaging intervention. Feasibility will be 
assessed as a composite outcome of recruitment rate, 
retention rate, adherence to renal dietary recommen-
dations, participant satisfaction and changes in dietary 
knowledge, attitude and behaviours (box 2). Adherence 
to dietary recommendations will be defined as participants 
meeting three of the four dietary guideline recommenda-
tions with respect to protein, potassium, phosphorus and 
sodium (table 1). Dietary intake will be assessed by two 
dietitians blinded to participant allocation, using the vali-
dated 24-hour pass methodology.32 Dietary recalls will be 
conducted in-person, or if this is not possible, on the tele-
phone with food models to assist with portion size estima-
tions. Dietary intake will be assessed using a 24-hour recall, 
of both a dialysis day and a non-dialysis day, to ensure that 
we are capture any differences in dietary intake on these 
days. Dietary intake will be assessed at baseline, 3 months 
and 6 months, and will be taken assessed within 2 weeks a 
participant’s scheduled review. Dietary intake data will be 
analysed using Xyris Software Foodworks V.9 Pty (using 
food databases AUSNUT 2011–2013, Aus Foods 2017, 
Aus Brands 2017).
After completion of the 6-month follow-up, a qualita-
tive process evaluation33 will be undertaken using semi-
structured interviews conducted among a subset of 25–30 
purposively sampled participants from the KIDNEYTEXT 
intervention group. Semistructured interviews will elicit 
participants’ perspectives regarding their satisfaction, 
acceptability and use of KIDNEYTEXT, and also their views 
and attitudes regarding changes in dietary behaviours, 
self-monitoring, decision-making and problem solving 
as a result of the KIDNEYTEXT intervention. With the 
consent of the participants, all interviews will be audio-
recorded and transcribed verbatim. The transcripts will 
be entered in the computer software package ‘HyperRE-
SEARCH V.3.0’ for storage, coding and searching of data. 
The audio recordings will be stored in a password-pro-
tected computer drive and hardcopy transcripts will be 
stored in a locked cabinet.
Secondary outcomes (outlined in table 1) will be 
assessed by two dietitians blinded to participant alloca-
tion, and include changes in serum potassium, serum 
phosphate, interdialytic weight gain, dietary quality 
and nutritional status. Dietary quality will be evaluated 
using the Australian Healthy Eating Index34 which uses 
seven parameters to assess the quality of a person’s diet. 
Nutritional status will be assessed using the Patient-Gen-
erated Subjective Global Assessment. Quality of life will 
be measured using the EQ-5D-5L instrument.35 The 
EQ-5D-5L is a standardised instrument for measuring 
generic health status using five dimensions of health rated 
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on a five point scale and a rating of overall health status 
using a visual analogue scale. All secondary outcomes will 
be measured at baseline, 3 months and 6 months, except 
for nutritional status which will be assessed at baseline 
and 6 months only.
Additional exploratory outcomes will also be measured 
at baseline and 6 months and comparisons made between 
the control and the KIDNEYTEXT intervention groups. 
Exploratory outcomes will include biochemical parame-
ters (urea, albumin, bicarbonate, parathyroid hormone, 
glycated haemoglobin), blood pressure (predialysis 
and postdialysis) and healthcare utilisation. Healthcare 
utilisation will be estimated from participant self-re-
ported records of their healthcare-related appointments 
(including general practitioner, medical specialists and 
allied health) using a calendar supplied by the research 
team. Any hospital and emergency department admis-
sions will be collected from medical records. Data 
relating to dialysis prescription (eg, dialysate composi-
tion, frequency and duration of dialysis) and dialysis-re-
lated medications (eg, prescription details of phosphate 
binders, resonium and diuretics) will be collected at base-
line, 3 months and 6 months. The cost of implementation 
of the intervention, including cost of sending the text 
messages and software development, will be estimated.
An exploratory cost analysis from the perspective of the 
healthcare provider for the intervention compared with 
standard care, will be completed using costs estimated 
from the health service utilisation records and the cost 
of implementation of the intervention. The EQ-5D-5L 
scores will be used to calculate quality adjusted life years 
for the control and intervention groups. Although the 
main purpose is to determine the feasibility of collecting 
healthcare utilisation and QOL in this patient popula-
tion, should the data be sufficiently robust, a preliminary 
calculation of an incremental cost-effectiveness ratio may 
be possible.
randomisation
The random allocation sequence will be in a 2:1 (inter-
vention:control) allocation ratio stratified by geograph-
ical location (Western Sydney, South Eastern Sydney). 
Randomisation will occur via a computerised randomisa-
tion programme that will be accessible by study staff with 
username and password through a web interface. Alloca-
tion will be concealed from study personnel undertaking 
assessments until the completion of the trial. Participants 
will be notified of their allocation via text message and 
will be asked not to disclose their allocation to study 
personnel.
blinding
Blinded assessments will be conducted by two dietitians 
at baseline, 3 months and 6 months in face-to-face or tele-
phone interviews. Prior to 3-month and 6-month reviews, 
participants will be sent a text message reminding them 
not to reveal their allocation to the outcome assessors. A 
statistician analysing data will also be blinded to partici-
pant allocation.
statistical analysis
A sample size of 129 participants, 86 in the intervention 
arm and 43 in the control arm, provide 80% power to 
detect an increase from 10% to 35% on adherence to 
dietary recommendations, with a significance level of 
0.05. The analysis will follow an intention-to-treat prin-
ciple. Balance across baseline characteristics (age, gender, 
haemodialysis type, dialysis vintage, dietary intake, 
biochemistry and interdialytic weight gains) will be 
checked. Continuous variables will be compared between 
box 2 Primary, secondary and exploratory outcome 
measures
Primary outcome (measured at baseline, 3 months and 
6 months)
Feasibility will be measured using:Feasibility will be measured using:
 ► Adherence to dietary recommendations. This will be measured us-
ing the 24-hour pass methodology to assess dietary intake with 
particular focus on renal dietary components: protein, potassium, 
phosphorous and sodium intake compared with renal dietary guide-
line recommendations. Adherence will be defined as meeting three 
of the four nutrition guidelines.
 – Dietary protein intake ≥1.2 g of protein per kilogram of ideal body 
weight per day.
 – Dietary potassium intake ≤1 mmol of potassium per kilogram of 
ideal body weight per day.
 – Dietary phosphate intake ≤1000 mg phosphorus per day.
 – Dietary sodium intake ≤2300 mg sodium per day.
 ► Recruitment rate.
 ► Drop-out rate.
 ► Participant satisfaction (measured using a 7-point Likert scale).
 ► Semistructured interviews to describe perspectives on participating 
in the trial, use of the intervention information, self-monitoring be-
haviours, decision-making, problem solving and behaviour change 
(only conducted in KIDNEYTEXT intervention group). Interviews will 
be conducted in-person or on the telephone within 8 weeks of com-
pleting the trial.
secondary outcomes (measured at baseline, 3 months and 
6 months)
 ► Serum electrolytes (potassium, phosphate).
 ► Interdialytic weight gains (average of the previous three haemodi-
alysis sessions).
 ► Changes in nutritional status as measured using the Patient-
Generated Subjective Global Assessment tool.
 ► Change in quality of life scores measured using EQ-5D-5L.
 ► Change in dietary quality measured using the Australian Healthy 
Eating Index.
 ► The mean change in the intake of renal-specific dietary components 
across all time points.
Exploratory outcomes (measured at baseline and 6 months)
 ► Blood pressure within recommended targets for patients on 
haemodialysis.
 ► Serum parathyroid hormone, urea, bicarbonate, albumin levels.
 ► Glycaemic control, measured using glycated haemoglobin levels 
(HbA1c) (subgroup analysis for patients with diabetes).
 ► Healthcare utilisation.
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groups using t-tests or Wilcoxon tests, according to their 
distribution. The χ2 test will be used to compare propor-
tions. Logistic and linear mixed models will be used to 
analyse the longitudinal measurements of categorical 
and continuous outcomes, respectively. In particular, the 
interaction between time and group will allow for overall 
comparison between the two groups. Adjustment for 
unbalanced baseline characteristics will be considered in 
the analysis. A significance level of 5% will be used.
safety and monitoring
If a participant is found to have a serum potassium level 
>6 mmol/L study personnel will alert dialysis staff. If 
a participant is commenced on a long-term (ie, longer 
than 1 month) dietary regime, that is, incongruent with 
standard renal dietary education (eg, immediately post 
bariatric surgery, total parenteral nutrition, complete 
enteral nutrition) during the study period the interven-
tion will be ceased.
EthICs And dIssEMInAtIon
The findings of this study will be disseminated via scien-
tific forums including peer-reviewed publications and 
presentations at international conferences. The study 
will be administered by the Westmead Clinical School, 
The University of Sydney, with the design and conduct 
overseen by a project management committee (authors). 
This committee has experience in large-scale clinical 
trials, qualitative research, health economics, renal medi-
cine, renal dietetics and health policy implementation. 
Written and informed consent will be obtained from all 
participants.
dIsCussIon
This study will evaluate a novel intervention to improve 
dietary behaviours in a haemodialysis population by using 
widely available and used mobile phone text messaging 
technology. Interventions using simple, inexpensive tech-
nology provide an opportunity to complement current 
dietary care and provide patients with more consistent 
support, particularly for those in resource poor settings 
and for those living in geographically isolated areas.
Rigorous studies are needed to evaluate the effec-
tiveness of a mobile phone text message intervention 
targeting behaviour change in the haemodialysis popu-
lation. No known studies have used mobile phone text 
messaging to improve dietary behaviours in a CKD or 
haemodialysis population; however, there is evidence that 
utilising mobile phone text messaging to improve dietary 
and clinical outcomes is feasible and effective in patients 
with coronary heart disease.21 36 37 Additionally, the 
content, level of individualisation, frequency and timing 
of text messages and level of interaction between health-
care professional and patient need to be determined. The 
current study will explore these important issues.
This KIDNEYTEXT trial will provide robust evidence 
about the feasibility of a targeted text messaging interven-
tion to improve dietary behaviours and clinical outcomes 
in a haemodialysis population. Interventions to improve 
patients’ knowledge and motivation to alter their dietary 
behaviours in this population are needed to enhance 
patients’ quality of life and clinical care and are seen as a 
high priority for both patients and clinicians. This inter-
vention has the potential as a cost-effective, readily acces-
sible and simple method to improve patients’ dietary 
knowledge and behaviours.
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